Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryusuke Hayashi

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cancer Immunology, Immunotherapy : CII|May 12, 2023
Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancerHidekiyo Yamaki, Michihisa Kono, Risa Wakisaka, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2020
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancerMizuho Ohara, Kenzo Ohara, Takumi Kumai, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2021
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machineryMichihisa Kono, Takumi Kumai, Ryusuke Hayashi, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatmentMarino Nagata, Akemi Kosaka, Yuki Yajima, et al.
Cancer Science|January 27, 2024
Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinomaToshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, et al.
The Journal of Experimental Medicine|September 24, 2021
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytesAkemi Kosaka, Kei Ishibashi, Toshihiro Nagato, et al.
Oncology Letters|April 12, 2021
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancerSatoshi Okazaki, Takaaki Sasaki, Shunsuke Yasuda, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2025
Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinomaHiroki Komatsuda, Toshihiro Nagato, Akemi Kosaka, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapyToshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, et al.
Oncoimmunology|January 18, 2021
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinomaRyusuke Hayashi, Toshihiro Nagato, Takumi Kumai, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|May 12, 2023
Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancerHidekiyo Yamaki, Michihisa Kono, Risa Wakisaka, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2020
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancerMizuho Ohara, Kenzo Ohara, Takumi Kumai, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2021
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machineryMichihisa Kono, Takumi Kumai, Ryusuke Hayashi, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatmentMarino Nagata, Akemi Kosaka, Yuki Yajima, et al.
Cancer Science|January 27, 2024
Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinomaToshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, et al.
The Journal of Experimental Medicine|September 24, 2021
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytesAkemi Kosaka, Kei Ishibashi, Toshihiro Nagato, et al.
Oncology Letters|April 12, 2021
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancerSatoshi Okazaki, Takaaki Sasaki, Shunsuke Yasuda, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2025
Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinomaHiroki Komatsuda, Toshihiro Nagato, Akemi Kosaka, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapyToshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, et al.
Oncoimmunology|January 18, 2021
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinomaRyusuke Hayashi, Toshihiro Nagato, Takumi Kumai, et al.
Pageof 5